Sun Pharma reports Q2 profit growth of 3%
pre-market1 source ↓written by the desknot a recommendation
- reflecting
- 2.6% YoY increase
- Revenue rose
- 9% YoY
- ₹14,405 cr
- of total revenue
- 20.2%
Sun Pharmaceutical Industries announced a net profit of ₹3,118 cr for Q2 FY26, reflecting a 2.6% YoY increase. Revenue rose 9% YoY to ₹14,405 cr. The EBITDA margin stood at 31.3%, with significant growth in the Global Innovative Medicines segment, which contributed 20.2% of total revenue. This performance may enhance investor sentiment in the pharma sector.
Not investment advice. For informational purposes only.